Uptake of [3H]-fosfomycin into cells of enterohemorrhagic Escherichia coli O157 and E. coli non-O157

Clinica Chimica Acta

Volumn 279, Issue 1-2, 1999, Pages 175-178

  Tsuboi, Isami ^a   Ida, Hirohisa ^a   Yoshikawa, Eiji ^a   Hiyoshi, Suehiro ^a   Yamaji, Emiko ^b   Nakayama, Issei ^b   O'Hara, Koji ^c   Nonomiya, Tomoko ^c   Shigenobu, Fritz ^c   Taniguchi, Kazuo ^c   Shimizu, Masaki ^c   Sawai, Tetsuo ^c   Mizuoka, Keiji ^a  

^a BML   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Enterohemorrhagic Escherichia coli; Fosfomycin; O157; Uptake

Indexed keywords

FOSFOMYCIN; RADIOISOTOPE; TRITIUM;

CONTROLLED STUDY; DIARRHEA; DRUG URINE LEVEL; ESCHERICHIA COLI O157; HEMOLYTIC UREMIC SYNDROME; HEMORRHAGIC COLITIS; LETTER; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; ESCHERICHIA COLI; METABOLISM; MICROBIOLOGICAL EXAMINATION;

ESCHERICHIA COLI;

ESCHERICHIA COLI; ESCHERICHIA COLI O157; FOSFOMYCIN; MICROBIAL SENSITIVITY TESTS; TRITIUM;

EID: 0032586825     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00168-5     Document Type: Article

References (13)

1. Tsuboi I., Ida H., Yoshikawa E., Hiyoshi S., Yamaji E., Nakayama I., O'Hara K., Nonomiya T., Shigenobu F., Shimizu M., Sawai T., Mizuoka K. Antibiotic susceptibility of enterohemorrhagic Escherichia coli O157:H7 isolated from an outbreak in Japan in 1996. Antimicrob. Agents Chemother. 42:1998;431-432.
2. Japan Society of Chemotherapy, Method of MIC determination by microdilution method. Chemotherapy (Tokyo). 1990;38:102-5.
3. National Committee for Clinical Laboratory Standards, 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
4. O'Hara K. Two different types of fosfomycin resistance in clinical isolates of Klebsiella pneumoniae. FEMS Microb. Lett. 14:1993;9-16.
5. Kahan F.M., Kahan J.S., Casssidy P.J., Kropp H. The mechanism of action of fosfomycin (Phosphonomycin). Ann. N.Y. Acad. Sci. 235:1974;364-386.
6. Kim D.H., Lees J.W., Kempsell K.E., Lane W.S., Duncan K., Walsh C. Characterization of a Cys 115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. Biochemistry. 35:1996;4923-4928.
7. Leon J., Garcia-Lobo J.M., Ortiz J.M. Fosfomycin resistance plasmids do not affect fosfomycin transport into Escherichia coli. Antimicrob. Agents Chemother. 21:1982;608-612.
8. Arca P., Reguera G., Hardisson C. Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey. J. Antimicrob. Chemother. 40:1997;393-399.
9. Mendoza C., Garcia J.M., Llaneza J., Mendez F.J., Hardisson C., Ortiz J.M. Plasmid-determined resistance to fosfomycin in Serratia marcescens. Antimicrob. Agents Chemother. 18:1980;215-219.
10. Suarez J.E., Mendoza M.C.E. Plasmid-encoded fosfomycin resistance. Antimicrob. Agents Chemother. 35:1991;791-795.
11. O'Hara K., Hashimoto H. Mechanism of fosfomycin-resistance in clinical isolates. Jpn. J. Antibiot. 49:1996;533-543.
12. O'Hara K., Kotake J., Ohmiya K., Kono M. Fosfomycin-inactivating enzyme from clinically isolated Pseudomonas aeruginosa. Chemotherapy. 36:1988;905-910.
13. O'Hara K., Nakamura A., Shigenobu F., Chen J., Sawai T. Combination effect of fosfomycin to b-lactam, aminoglycoside, and macrolide antibiotics\against clinical isolates of Klebsiella pneumoniae. Jpn. J. Antibiot. 50:1997;704-710.